Robert Rifkin, MD from Rocky Mountain Cancer Center discusses baseline disease characteristics & diagnostic patterns for NDMM – observations over time in Cohort 1 and Cohort 2 at the 2017 American Society of Hematology.
Baseline Disease Characteristics & Diagnostic Patterns for NDMM – Observations over time in Cohort 1 and Cohort 2
